NEW YORK (GenomeWeb) – Antibiotic resistance diagnostics firm MicrobeDx today announced it has received up to $3.5 million in funding from CARB-X.

The award will be used by Los Angeles-based MicrobeDx to develop its diagnostic technology, which uses a compact desktop device to detect the presence of bacteria in clinical urine specimens, and to which antibiotics they are susceptible. Bacteria can be detected within 30 minutes, while complete antimicrobial susceptibility detection can be completed within three hours with the system, the company said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Feb
21
Sponsored by
L7 Informatics

This webinar will provide a first-hand look at how Gradalis, a clinical-stage immunotherapy developer, is using an information management solution from L7 to streamline its research, clinical, and manufacturing operations.

Mar
20
Sponsored by
Qiagen

This webinar will discuss how a new multiplexed testing system can help physicians rapidly diagnose acute respiratory infections in the near-patient setting.

Mar
21
Sponsored by
Loop Genomics

This webinar provides a comparison of next-generation sequencing (NGS) approaches for human transcriptome sequencing, including short-read Illumina sequencing and synthetic long-read sequencing technology.

Mar
26
Sponsored by
PerkinElmer

This webinar will address the current status and future directions for massively high-throughput genomics for plant and animal breeding and research.